Nuformix plc
NFX.L · LSE
9/30/2024 | 9/30/2023 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £460 | £1,871 | £2,025 | £5,835 |
| - Cash | £20 | £203 | £259 | £464 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £440 | £1,668 | £1,766 | £5,371 |
| Revenue | £0 | £0 | – | £50 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | -£37 | – | £11 |
| % Margin | – | – | – | 22.7% |
| EBITDA | -£477 | -£582 | – | -£1,233 |
| % Margin | – | – | – | -2,466.6% |
| Net Income | -£3,641 | -£573 | – | -£1,109 |
| % Margin | – | – | – | -2,218% |
| EPS Diluted | -0.005 | -0.001 | – | -0.002 |
| % Growth | -475% | – | – | – |
| Operating Cash Flow | -£332 | -£397 | -£433 | -£1,346 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£332 | -£397 | -£433 | -£1,346 |